ATRC AtriCure, Inc.
Healthcare$28.81+1.84%ClosedMarket Cap: $1.46B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.78
P/S
2.59
EV/EBITDA
57.95
DCF Value
$-2.95
FCF Yield
3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
-0.4%
Net Margin
-0.8%
ROE
-1.0%
ROA
-0.7%
ROIC
-0.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $141.2M | 77.4% | $526.0K | $108.0K | $— | — |
| Q4 null | $140.5M | 74.4% | $3.5M | $1.8M | $— | — |
| FY null | $534.5M | 74.4% | $-3.4M | $-11.4M | $— | — |
| Q3 null | $134.3M | 75.5% | $208.0K | $-267.0K | $— | — |
| Q2 null | $136.1M | 74.5% | $-6.2M | $-6.2M | $— | — |
| Q1 null | $123.6M | 74.9% | $-6.0M | $-6.7M | $— | — |
| Q4 null | $124.3M | 74.5% | $-14.5M | $-15.6M | $— | — |
| FY null | $465.3M | 74.7% | $-40.0M | $-44.7M | $— | — |
| Q3 null | $115.9M | 74.9% | $-7.4M | $-7.9M | $— | — |
| Q2 null | $116.3M | 74.0% | $-7.2M | $-8.0M | $— | — |
| Q1 null | $108.9M | 74.0% | $-10.9M | $-13.3M | $— | — |
| Q4 2023 | $106.5M | 74.2% | $-8.7M | $-9.8M | $-0.21 | — |